SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $996,668 | +25.1% | 215,729 | +118.7% | 0.01% | 0.0% |
| Q4 2022 | $796,987 | -41.2% | 98,637 | -40.1% | 0.01% | -12.5% |
| Q1 2022 | $1,355,000 | +12.3% | 164,790 | +103.1% | 0.01% | +33.3% |
| Q4 2021 | $1,207,000 | +14.7% | 81,129 | +45.6% | 0.01% | -14.3% |
| Q3 2021 | $1,052,000 | -35.8% | 55,709 | -36.8% | 0.01% | -30.0% |
| Q2 2021 | $1,639,000 | -47.6% | 88,169 | -35.8% | 0.01% | -52.4% |
| Q1 2021 | $3,125,000 | – | 137,303 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $33,918,000 | 14.78% |
| Samsara BioCapital, LLC | 1,675,579 | $31,149,000 | 3.84% |
| First Light Asset Management, LLC | 2,072,875 | $38,535,000 | 2.31% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,253,000 | 1.88% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $18,616,000 | 1.72% |
| Opaleye Management Inc. | 496,900 | $9,237,000 | 1.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,590,000 | 0.68% |
| Parkman Healthcare Partners LLC | 163,389 | $3,037,000 | 0.66% |
| Eventide Asset Management | 2,370,975 | $44,076,000 | 0.59% |
| BVF INC/IL | 826,825 | $15,371,000 | 0.58% |